GW Pharmaceuticals turns over $108M in Q4 sales thanks to CBD-based medicine
Bethan Rose Jenkins, Cannabis News Writer/Editorial
• January 27, 2020
CEO of GW Pharma talks about Epidiolex getting FDA approval
The DEA must accurately categorize CBD within 90 days of the approval
Bethan Rose Jenkins, Cannabis News Writer/Editorial
• July 2, 2018
Will Epidiolex be the first cannabis-based drug to be approved as an epilepsy treatment?
Bethan Rose Jenkins, Cannabis News Writer/Editorial
• May 3, 2018
Load More Stories